tiprankstipranks
Trending News
More News >
ALX Oncology Holdings (ALXO)
NASDAQ:ALXO
US Market
Advertisement

ALX Oncology Holdings (ALXO) Ratios

Compare
413 Followers

ALX Oncology Holdings Ratios

ALXO's free cash flow for Q2 2025 was $0.00. For the 2025 fiscal year, ALXO's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.52 5.24 9.57 24.00 69.99
Quick Ratio
4.52 5.24 10.19 24.00 69.99
Cash Ratio
1.02 0.62 9.99 23.78 69.99
Solvency Ratio
-3.74 -3.03 -2.84 -4.83 -0.10
Operating Cash Flow Ratio
-5.60 -3.62 -3.15 -4.45 -6.17
Short-Term Operating Cash Flow Coverage
-20.89 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 54.35M$ 135.82M$ 227.94M$ 349.88M$ -1.83M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.07 0.03 <0.01 0.00
Debt-to-Equity Ratio
0.05 0.09 -0.03 >-0.01 0.00
Debt-to-Capital Ratio
0.05 0.08 -0.03 >-0.01 0.00
Long-Term Debt-to-Capital Ratio
0.10 0.05 -0.03 0.00 0.00
Financial Leverage Ratio
1.48 1.28 -0.94 -1.88 -3.68
Debt Service Coverage Ratio
-17.13 -101.22 0.00 -6.42K -53.89
Interest Coverage Ratio
-72.24 -108.80 0.00 -6.43K -53.84
Debt to Market Cap
0.34 0.02 0.02 0.00 0.00
Interest Debt Per Share
0.09 0.44 0.26 0.02 0.02
Net Debt to EBITDA
0.14 0.03 2.23 4.35 9.99
Profitability Margins
Gross Profit Margin
-22.12%0.00%0.00%0.00%9.05%
EBIT Margin
-13236.06%0.00%0.00%0.00%-3693.99%
EBITDA Margin
-13288.48%0.00%0.00%0.00%-3676.90%
Operating Profit Margin
-14014.75%0.00%0.00%0.00%-3693.99%
Pretax Profit Margin
-13430.07%0.00%0.00%0.00%-3849.32%
Net Profit Margin
-13430.07%0.00%0.00%0.00%-3869.71%
Continuous Operations Profit Margin
-13430.07%0.00%0.00%0.00%-3869.71%
Net Income Per EBT
100.00%100.00%100.05%99.97%100.53%
EBT Per EBIT
95.83%94.44%96.85%99.92%104.20%
Return on Assets (ROA)
-122.30%-66.30%-40.29%-21.95%-10.49%
Return on Equity (ROE)
-115.67%-84.76%37.94%41.32%38.59%
Return on Capital Employed (ROCE)
-159.08%-82.44%-45.81%-22.90%-10.16%
Return on Invested Capital (ROIC)
-149.22%-81.81%-45.67%-22.85%-10.21%
Return on Tangible Assets
-122.30%-66.30%-40.29%-21.95%-10.49%
Earnings Yield
-330.18%-25.12%-26.92%-9.64%-1.33%
Efficiency Ratios
Receivables Turnover
1.30 0.00 0.00 0.00 0.00
Payables Turnover
0.13 0.10 0.18 0.20 268.75
Inventory Turnover
0.00 0.00 -0.08 0.00 0.00
Fixed Asset Turnover
0.58 0.00 0.00 0.00 22.73
Asset Turnover
<0.01 0.00 0.00 0.00 <0.01
Working Capital Turnover Ratio
0.01 0.00 0.00 0.00 <0.01
Cash Conversion Cycle
-2.58K -3.75K -6.42K -1.87K -1.36
Days of Sales Outstanding
280.06 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 -4.41K 0.00 0.00
Days of Payables Outstanding
2.86K 3.75K 2.01K 1.87K 1.36
Operating Cycle
280.06 0.00 -4.41K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-1.97 -3.03 -2.19 -1.69 -0.96
Free Cash Flow Per Share
-1.98 -3.06 -2.23 -1.81 -0.96
CapEx Per Share
<0.01 0.03 0.04 0.12 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.02 1.07 1.00
Dividend Paid and CapEx Coverage Ratio
-333.83 -102.33 -62.52 -13.83 -1.13K
Capital Expenditure Coverage Ratio
-333.83 -102.33 -62.52 -13.83 -1.24K
Operating Cash Flow Coverage Ratio
-34.67 -7.58 -8.55 -91.78 0.00
Operating Cash Flow to Sales Ratio
-121.53 0.00 0.00 0.00 -32.39
Free Cash Flow Yield
-299.69%-20.57%-19.76%-8.43%-1.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.30 -3.98 -3.71 -10.38 -75.09
Price-to-Sales (P/S) Ratio
40.67 0.00 0.00 0.00 2.91K
Price-to-Book (P/B) Ratio
0.55 3.37 -1.41 -4.29 -28.98
Price-to-Free Cash Flow (P/FCF) Ratio
-0.33 -4.86 -5.06 -11.86 -89.63
Price-to-Operating Cash Flow Ratio
-0.33 -4.91 -5.14 -12.72 -89.70
Price-to-Earnings Growth (PEG) Ratio
-0.03 -0.17 -0.08 -0.13 -0.64
Price-to-Fair Value
0.55 3.37 -1.41 -4.29 -28.98
Enterprise Value Multiple
-0.17 -4.01 -1.53 -6.03 -69.04
Enterprise Value
19.05M 634.88M 186.21M 503.29M 3.00B
EV to EBITDA
-0.17 -4.01 -1.53 -6.03 -69.04
EV to Sales
21.94 0.00 0.00 0.00 2.54K
EV to Free Cash Flow
-0.18 -4.82 -2.05 -6.89 -78.30
EV to Operating Cash Flow
-0.18 -4.87 -2.09 -7.39 -78.36
Tangible Book Value Per Share
1.21 4.41 6.47 9.01 0.00
Shareholders’ Equity Per Share
1.21 4.41 -8.00 -5.01 -2.97
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 >-0.01 <0.01 >-0.01
Revenue Per Share
0.02 0.00 0.00 0.00 0.03
Net Income Per Share
-2.18 -3.74 -3.03 -2.07 -1.15
Tax Burden
1.00 1.00 1.00 1.00 1.01
Interest Burden
1.01 1.01 1.00 1.00 1.04
Research & Development to Revenue
105.89 0.00 0.00 0.00 24.50
SG&A to Revenue
30.60 0.00 0.00 0.00 12.53
Stock-Based Compensation to Revenue
23.23 0.00 0.00 0.00 4.60
Income Quality
0.90 0.81 0.72 0.82 0.84
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis